Doc,

Chilbear, you and I appear to share a common strategy regards acquiring more CGNH shares if the market makers will sell them to us. I remain optimistic that the POC analyzer will produce comparable results and if/when this happens the utility of the beads will also be validated.

Cardiogenics will then be the proud owner of two separate and distinct technology platforms with significant commercial potential.

Ante